Journal Logo

Simultaneous Sessions IV: Refining biomarkers for AML outcome

S1614 CHROMOSOMAL ABNORMALITIES DETERMINE OUTCOME IN NPM1MUT/FLT3-ITDNEG/LOW ACUTE MYELOID LEUKEMIA

Angenendt, L.1; Röllig, C.2; Montesinos, P.3; Martínez-Cuadrón, D.3; Barragan, E.3; García, R.4; Botella, C.5; Martínez, P.6; Ravandi, F.7; Kadia, T.7; Kantarjian, H.M.7; Cortes, J.7; Juliusson, G.8; Lazarevic, V.8; Höglund, M.9; Lehmann, S.9; Recher, C.10; Pigneux, A.11; Bertoli, S.10; Dumas, P.-Y.11; Dombret, H.12; Preudhomme, C.13; Micol, J.-B.14; Terré, C.15; Ráčil, Z.16; Novák, J.17; Žák, P.18; Wei, A.H.19; Tiong, I.S.19; Wall, M.20; Estey, E.21; Shaw, C.21; Exeler, R.22; Wagenführ, L.2; Stölzel, F.2; Thiede, C.2; Stelljes, M.1; Lenz, G.1; Mikesch, J.-H.1; Serve, H.23; Ehninger, G.2; Berdel, W.E.1; Kramer, M.2; Krug, U.24; Schliemann, C.1

Author Information
doi: 10.1097/01.HS9.0000564704.06449.f2
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.